Genetic variations, including de novo and mitochondrial DNA mutations, play a significant role in the development of cerebral palsy, according to a large-scale whole-genome sequencing study.
Combining polygenic risk scores with family history and pathogenic variants improves breast cancer risk stratification, enabling more personalized screening approaches.